IL-15/NKG2D signaling-mediated activation of CD8<sup>+</sup> T cell bypass pathways in sepsis-induced immune injury. [PDF]
Wang S, Liu L, Mao R, Liu Y, Chai Y.
europepmc +1 more source
Engineered PD1-NKG2D Dual-CAR NK92 cells broaden antitumor target recognition in preclinical tumor models. [PDF]
Jin X +8 more
europepmc +1 more source
Targeting the NKG2D axis in head and neck squamous cell carcinoma: from molecular insights to clinical applications. [PDF]
Alijanizadeh P +8 more
europepmc +1 more source
CAR-NK cell immunotherapy: a comprehensive review of engineering platforms, clinical applications in hematological and solid tumors. [PDF]
Awadallah SM +5 more
europepmc +1 more source
Natural Killer Cells Dominate the Hyperacute Lymphocyte Response to Major Trauma and Are Associated with Organ Dysfunction. [PDF]
Shepherd JM +6 more
europepmc +1 more source
Immunogenetic and Transcriptomic Evidence Implicating the NKG2D-MICA/MICB Axis in CALR-Mutated Myeloproliferative Neoplasms. [PDF]
Shivarov V +6 more
europepmc +1 more source
Engineering immune cell engagers: From molecular constructs to biomaterial platforms. [PDF]
Park HW, Kim S.
europepmc +1 more source
Challenges and Opportunities of γδ T Cell-Based Immunotherapy for Glioblastoma. [PDF]
Chao CC +5 more
europepmc +1 more source

